From the Department of Cardiology, Rabin Medical Center, Petah Tikva, Israel (G.W., O.Z., P.C., A.A., R.K.); and Sackler Faculty of Medicine, Tel-Aviv University, Israel (G.W., O.Z., P.C., A.A., R.K.).
Circ Cardiovasc Interv. 2018 Mar;11(3):e006000. doi: 10.1161/CIRCINTERVENTIONS.117.006000.
Coronary artery disease (CAD) is highly prevalent in patients undergoing transcatheter aortic valve replacement. In the overall CAD population, complete revascularization or reasonable incomplete revascularization (ICR) is associated with improved outcomes; whether the same applies for the transcatheter aortic valve replacement population is still a matter of debate.
We conducted a systematic review and meta-analysis of studies that examined the prognostic effect of revascularization completeness in patients undergoing transcatheter aortic valve replacement using the residual SYNTAX score (Synergy Between PCI With Taxus and Cardiac Surgery) to separate between reasonable ICR and ICR (using the individual threshold used by each study). Six studies with a total of 3107 patients were included. The duration of follow-up ranged from 0.7 to 3 years. Overall, ICR was associated with an increased risk for mortality. This was true when comparing ICR patients to those with no CAD (odds ratio, 1.85; 95% confidence interval, 1.42-2.40; <0.01), to those with reasonable ICR (odds ratio, 1.69; 95% confidence interval, 1.26-2.28; <0.001), or to both groups combined (odds ratio, 1.71; 95% confidence interval, 1.36-2.16; <0.001). On the contrary, patients in the reasonable ICR category did not show an increased risk for mortality when compared with those with no CAD (odds ratio, 1.11; 95% confidence interval, 0.89-1.39; =0.33).
Our results suggest that for patients with CAD undergoing transcatheter aortic valve replacement, a residual SYNTAX score-guided revascularization strategy may carry significant benefits in terms of mortality. Adequate revascularization may offer a unique and valuable opportunity to improve the prognosis of these patients.
在接受经导管主动脉瓣置换术的患者中,冠状动脉疾病(CAD)的患病率很高。在整个 CAD 人群中,完全血运重建或合理的不完全血运重建(ICR)与改善预后相关;对于经导管主动脉瓣置换术患者,同样的情况是否适用仍存在争议。
我们使用残余 SYNTAX 评分(经皮冠状动脉介入治疗与心脏手术之间的协同作用)进行了系统评价和荟萃分析,以区分合理的 ICR 和 ICR(使用每个研究使用的个体阈值),研究了经导管主动脉瓣置换术患者血运重建完全程度对预后的影响。共有 6 项研究,总计 3107 例患者纳入研究。随访时间从 0.7 年到 3 年不等。总的来说,ICR 与死亡率增加相关。这一结果在比较 ICR 患者与无 CAD 患者(比值比,1.85;95%置信区间,1.42-2.40;<0.01)、与合理 ICR 患者(比值比,1.69;95%置信区间,1.26-2.28;<0.001)或两组患者(比值比,1.71;95%置信区间,1.36-2.16;<0.001)时均成立。相反,与无 CAD 患者相比,合理 ICR 患者的死亡率无增加风险(比值比,1.11;95%置信区间,0.89-1.39;=0.33)。
我们的研究结果表明,对于接受经导管主动脉瓣置换术的 CAD 患者,残余 SYNTAX 评分指导的血运重建策略可能在死亡率方面带来显著获益。充分的血运重建可能为改善这些患者的预后提供独特而有价值的机会。